RXST - RxSight, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $9.38 DETAILS

Stock News

Law Offices of Howard G. Smith Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces it is investigating potential claims against the board of directors of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) concerning whether the board breached its fiduciary duties to shareholders.IF YOU ARE A RXSIGHT, INC. (RXST) SHAREHOLDER, CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE.What Is The Investigation About?On July 8, 2025, after the market closed, RxSight reported preliminary second quarter.

Jul 08, 2026 08:00 AM • businesswire.com (Hide legal announcements)

The Law Offices of Frank R. Cruz Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) concerning whether the board breached its fiduciary duties to shareholders.IF YOU ARE A RXSIGHT, INC. (RXST) SHAREHOLDER, CLICK HERE TO PARTICIPATE.What Is The Investigation About?On July 8, 2025, after the market closed, RxSight reported preliminary second quarter 2025 financial results, revealing significant.

Jul 07, 2026 11:05 AM • businesswire.com (Hide legal announcements)

RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript

Jul 07, 2026 06:32 AM • seekingalpha.com

Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs

ALISO VIEJO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting intraocular lenses (PCIOLs).

Jul 06, 2026 12:15 PM • globenewswire.com

RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

ALISO VIEJO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product pipeline, following the announcement of the company's strategic collaboration with Alcon to develop and commercialize light-adjustable Presbyopia-Correcting Intraocular Lenses.

Jul 06, 2026 12:15 PM • globenewswire.com

RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

ALISO VIEJO, Calif. , July 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product pipeline, following the announcement of the company's strategic collaboration with Alcon to develop and commercialize light-adjustable Presbyopia-Correcting Intraocular Lenses.

Jul 06, 2026 12:15 PM • globenewswire.com

Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs

Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologies Collaboration aims to combine best-in-class PCIOL optics with first-in-class platform to enable fine-tuning of visual outcomes after cataract surgery ALISO VIEJO, Calif. , July 06, 2026 (GLOBE NEWSWIRE) -- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and RxSight, Inc.

Jul 06, 2026 12:15 PM • globenewswire.com

Did RxSight, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Jul 02, 2026 11:02 AM • prnewswire.com

RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum

ALISO VIEJO, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming Stifel 2026 Virtual Ophthalmology Forum. Management is scheduled to participate in a fireside chat on Tuesday, May 26, 2026, at 10:00 a.m. Pacific Time. A live and archived webcast of the presentation will be available on the company's investor relations website at https://investors.rxsight.com/.

May 19, 2026 12:10 PM • globenewswire.com

RxSight, Inc. (RXST) Presents at Bank of America Global Healthcare Conference 2026 Transcript

May 13, 2026 03:20 PM • seekingalpha.com

RxSight, Inc. (RXST) Q1 2026 Earnings Call Transcript

May 09, 2026 12:31 PM • seekingalpha.com

RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates

RxSight, Inc. (RXST) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.03 per share a year ago.

May 06, 2026 03:31 PM • zacks.com

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

ALISO VIEJO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended March 31, 2026.

May 06, 2026 12:05 PM • globenewswire.com

RxSight, Inc. to Present at the Bank of America Healthcare Conference

ALISO VIEJO, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., today announced plans to participate in the upcoming Bank of America Healthcare Conference. Management is scheduled to participate in a fireside chat on Wednesday, May 13, 2026, at 3:00 p.m. Pacific Time. A live and archived webcast of the presentation will be available on the company's investor relations website at https://investors.rxsight.com/.

Apr 29, 2026 12:10 PM • globenewswire.com

RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6

ALISO VIEJO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., today announced that it will report financial results for the first quarter after the market close on Wednesday, May 6, 2026. The company's management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Apr 22, 2026 12:10 PM • globenewswire.com

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

WASHINGTON, April 08, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced, in advance of the 2026 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, that over 300,000 Light Adjustable Lens® (LAL®) implants have been performed since launch, marking a significant milestone in the company's pursuit to make customized vision correction widely available to patients.

Apr 08, 2026 12:05 PM • globenewswire.com

RxSight (NASDAQ:RXST) Trading Down 3.7% – Time to Sell?

Shares of RxSight, Inc. (NASDAQ: RXST - Get Free Report) fell 3.7% on Tuesday. The company traded as low as $6.75 and last traded at $6.76. 430,271 shares were traded during trading, a decline of 45% from the average session volume of 784,773 shares. The stock had previously closed at $7.02. Analyst Ratings Changes A

Apr 07, 2026 10:39 PM • defenseworld.net

RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference

ALISO VIEJO, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming 25th Annual Needham Virtual Healthcare Conference. Management is scheduled to participate in a fireside chat on Thursday, April 16, 2026, at 8:00 a.m. Pacific Time. A live and archived webcast of the presentation will be available on the company's investor relations website at https://investors.rxsight.com/.

Apr 02, 2026 12:10 PM • globenewswire.com

RxSight, Inc. (NASDAQ:RXST) Given Consensus Rating of “Reduce” by Analysts

RxSight, Inc. (NASDAQ: RXST - Get Free Report) has received a consensus recommendation of "Reduce" from the fifteen analysts that are covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the company. The average

Mar 16, 2026 10:24 PM • defenseworld.net

Short Interest in RxSight, Inc. (NASDAQ:RXST) Expands By 29.3%

RxSight, Inc. (NASDAQ: RXST - Get Free Report) was the target of a large increase in short interest in February. As of February 13th, there was short interest totaling 5,358,739 shares, an increase of 29.3% from the January 29th total of 4,144,635 shares. Approximately 14.4% of the company's stock are sold short. Based on an average

Mar 02, 2026 08:03 PM • defenseworld.net